ClinicalTrials.Veeva

Menu

The Risk for Clostridium Difficile Colitis During Hospitalization in Asymptomatic Carriers

A

Amos Yinnon

Status

Completed

Conditions

Colitis
Clostridium Difficile

Study type

Observational

Funder types

Other

Identifiers

NCT02063282
ShaareZMC

Details and patient eligibility

About

The investigators hypothesize that development of symptoms characteristic of Clostridium difficile infection will be 2-3 times higher in asymptomatic carriers, compared to that of non carriers and expect to find risk factors for development of symptomatic clostridium difficile.

Enrollment

394 patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • History of hospitalization in recent year, residence of a nursing home or institutions
  • Expected more than 48 hours hospitalization

Exclusion criteria

  • Colitis/ diarrhea
  • Rectal swab performed ≥48 hrs post arrival to hospital.

Trial design

394 participants in 2 patient groups

Clostridium difficile carriers
Clostridium difficile non carriers

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems